# Artiva Biotherapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/artiva-biotherapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 18 | | Claims under review | 1 | | Evidence records | 8 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T13:52:46.314178+00:00 | | Last reviewed | 2026-10-16T13:52:46.314178+00:00 | ## Identity - Legal name: Artiva Biotherapeutics, Inc. - Display name: Artiva Biotherapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T13:52:46.314178+00:00 | | Completeness | 0.364 | | Record Quality | 0.85 | | Directors | 8 | | Committees | 0 | | Governance events | 13 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | NOT_REVIEWED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Alison Moore, Ph.D.: Director. Status: current. Independent: true. Since: 2024-01-01. claim_id=alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:5 - Brian Daniels, M.D.: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:6 - Daniel Baker, Ph.D.: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:7 - Diego Miralles, M.D.: Director. Status: current. Independent: true. Since: 2024-01-01. claim_id=alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:8 - Elizabeth Hougen: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:9 - Fred Aslan, M.D.: Director. Status: current. Independent: false. Since: 2021-01-01. claim_id=alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:10 - Laura Stoppel, Ph.D.: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:11 - Yong-Jun Huh: Director. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:12 ## Executive leadership - Christopher P. Horan: Chief Technical Operations Officer. Status: current. claim_id=alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:13 - Fred Aslan, M.D.: President, Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:14 - Heather Raymon, Ph.D.: Senior Vice President of Research and Early Development. Status: current. claim_id=alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:15 - Jennifer Bush: Chief Operating Officer, Chief Legal Officer, Corporate Secretary and Compliance Officer [GC]. Status: current. claim_id=alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:16 - Neha Krishnamohan: Chief Financial Officer and Executive Vice President of Corporate Development [CFO]. Status: current. claim_id=alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:17 - Subhashis Banerjee, M.D.: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:18 ## Governance events - EXECUTIVE_APPOINTED: Christopher P. Horan executive of Artiva Biotherapeutics, Inc., effective 2025-04-29. Effective: 2025-04-29. Detected: 2026-10-16T13:52:46.314178+00:00. event_id=alpha:event:transition:1urewdfr7qggv - CEO_CHANGED: Fred Aslan, M.D. executive of Artiva Biotherapeutics, Inc., effective 2025-04-29. Effective: 2025-04-29. Detected: 2026-10-16T13:52:46.314178+00:00. event_id=alpha:event:transition:1brylwj2q0iab - EXECUTIVE_APPOINTED: Heather Raymon, Ph.D. executive of Artiva Biotherapeutics, Inc., effective 2025-04-29. Effective: 2025-04-29. Detected: 2026-10-16T13:52:46.314178+00:00. event_id=alpha:event:transition:178x0yf1w7378r - GC_CHANGED: Jennifer Bush executive of Artiva Biotherapeutics, Inc., effective 2025-04-29. Effective: 2025-04-29. Detected: 2026-10-16T13:52:46.314178+00:00. event_id=alpha:event:transition:17002hhuhroxj - CFO_CHANGED: Neha Krishnamohan executive of Artiva Biotherapeutics, Inc., effective 2025-04-29. Effective: 2025-04-29. Detected: 2026-10-16T13:52:46.314178+00:00. event_id=alpha:event:transition:g886s0lkd4q6 - EXECUTIVE_APPOINTED: Subhashis Banerjee, M.D. executive of Artiva Biotherapeutics, Inc., effective 2025-04-29. Effective: 2025-04-29. Detected: 2026-10-16T13:52:46.314178+00:00. event_id=alpha:event:transition:1smod130nnit - DIRECTOR_APPOINTED: Daniel Baker, Ph.D. seat on Artiva Biotherapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T13:52:46.314178+00:00. event_id=alpha:event:transition:1wi8k55qywruv - DIRECTOR_APPOINTED: Alison Moore, Ph.D. seat on Artiva Biotherapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:52:46.314178+00:00. event_id=alpha:event:transition:52hdygfqevko - DIRECTOR_APPOINTED: Diego Miralles, M.D. seat on Artiva Biotherapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:52:46.314178+00:00. event_id=alpha:event:transition:1umpa2n1aaecvt - DIRECTOR_APPOINTED: Elizabeth Hougen seat on Artiva Biotherapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:46.314178+00:00. event_id=alpha:event:transition:udoygd1bgzzg9 - DIRECTOR_APPOINTED: Fred Aslan, M.D. seat on Artiva Biotherapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:46.314178+00:00. event_id=alpha:event:transition:18208mrz7uqil - DIRECTOR_APPOINTED: Brian Daniels, M.D. seat on Artiva Biotherapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:52:46.314178+00:00. event_id=alpha:event:transition:1g5ewwriecasv - DIRECTOR_APPOINTED: Laura Stoppel, Ph.D. seat on Artiva Biotherapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:52:46.314178+00:00. event_id=alpha:event:transition:6klnotvms95t ## Scoped resources - `alpha://company/artiva-biotherapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record - `alpha://company/artiva-biotherapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=identity - `alpha://company/artiva-biotherapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=corporate-structure - `alpha://company/artiva-biotherapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=board - `alpha://company/artiva-biotherapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=committees - `alpha://company/artiva-biotherapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=leadership - `alpha://company/artiva-biotherapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=ownership - `alpha://company/artiva-biotherapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=financials - `alpha://company/artiva-biotherapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=capital-structure - `alpha://company/artiva-biotherapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=compensation - `alpha://company/artiva-biotherapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=governance - `alpha://company/artiva-biotherapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/artiva-biotherapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=audit - `alpha://company/artiva-biotherapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=legal - `alpha://company/artiva-biotherapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=risk - `alpha://company/artiva-biotherapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=cyber - `alpha://company/artiva-biotherapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=ai-governance - `alpha://company/artiva-biotherapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=agents - `alpha://company/artiva-biotherapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=ecosystem - `alpha://company/artiva-biotherapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=events - `alpha://company/artiva-biotherapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=relationships - `alpha://company/artiva-biotherapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=assessments - `alpha://company/artiva-biotherapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Alison Moore, Ph.D.: Director. Claim: alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:5. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380. - Brian Daniels, M.D.: Director. Claim: alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:6. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380. - Daniel Baker, Ph.D.: Director. Claim: alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:7. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380. - Diego Miralles, M.D.: Director. Claim: alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:8. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380. - Elizabeth Hougen: Director. Claim: alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380. - Fred Aslan, M.D.: Director. Claim: alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:10. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380. - Laura Stoppel, Ph.D.: Director. Claim: alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:11. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380. - Yong-Jun Huh: Director. Claim: alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380. - Christopher P. Horan: Chief Technical Operations Officer. Claim: alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:13. Valid from: 2025-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:49a37cc3389be89f458b58ee5db7c12ead68f56520f3775cd0962b065313aab0. - Fred Aslan, M.D.: President, Chief Executive Officer and Director. Claim: alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:14. Valid from: 2025-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b0552ed2b752aeab85caefe6a60c553e7af5caa463fd1af30db554cd484b13f4. - Heather Raymon, Ph.D.: Senior Vice President of Research and Early Development. Claim: alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:15. Valid from: 2025-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:de182977583a51fd2c9fd5ba25ca90661a3e1c0a4dde16b15f505adda85310d7. - Jennifer Bush: Chief Operating Officer, Chief Legal Officer, Corporate Secretary and Compliance Officer. Claim: alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:16. Valid from: 2025-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:77659bafedc6e5c913c482dc6836adb367a41852660755b1d31ff448c335015b. - Neha Krishnamohan: Chief Financial Officer and Executive Vice President of Corporate Development. Claim: alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:17. Valid from: 2025-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:427131549f36eaf30a00009bf9306e06317ac17bc0c24d2d25b580bf8381043c. - Subhashis Banerjee, M.D.: Chief Medical Officer. Claim: alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:18. Valid from: 2025-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:43d76b5685f017fa9af49b1583fba8c340392541d87fed70966834ccb0b313f2. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Artiva Biotherapeutics, Inc.. Claim: alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:86d1db7134c4fa73c09679fe9b98e866071573eafaf970888b055b15799d8cf7. ## Entity Status - Public listing published. Claim: alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:86d1db7134c4fa73c09679fe9b98e866071573eafaf970888b055b15799d8cf7. ## Published Fact - US. Claim: alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:86d1db7134c4fa73c09679fe9b98e866071573eafaf970888b055b15799d8cf7. ## Security Listing - ARTV (NASDAQ). Claim: alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:security_listing:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:86d1db7134c4fa73c09679fe9b98e866071573eafaf970888b055b15799d8cf7. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:86d1db7134c4fa73c09679fe9b98e866071573eafaf970888b055b15799d8cf7: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/artiva-biotherapeutics-inc). - alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380: [Artiva Biotherapeutics, Inc. DEF 14A 2025-04-29](https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm). - alpha:projection-evidence:document:49a37cc3389be89f458b58ee5db7c12ead68f56520f3775cd0962b065313aab0: [ARTV DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm). - alpha:projection-evidence:document:b0552ed2b752aeab85caefe6a60c553e7af5caa463fd1af30db554cd484b13f4: [ARTV DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm). - alpha:projection-evidence:document:de182977583a51fd2c9fd5ba25ca90661a3e1c0a4dde16b15f505adda85310d7: [ARTV DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm). - alpha:projection-evidence:document:77659bafedc6e5c913c482dc6836adb367a41852660755b1d31ff448c335015b: [ARTV DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm). - alpha:projection-evidence:document:427131549f36eaf30a00009bf9306e06317ac17bc0c24d2d25b580bf8381043c: [ARTV DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm). - alpha:projection-evidence:document:43d76b5685f017fa9af49b1583fba8c340392541d87fed70966834ccb0b313f2: [ARTV DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/artiva-biotherapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/artiva-biotherapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/artiva-biotherapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Structured intelligence is not currently available. Existing published profile evidence remains accessible. ## Critical-risk oversight Snapshot as of 2026-10-17T03:30:12.084406+00:00; recorded 2026-10-17T03:30:12.084406+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.